Company Filing History:
Years Active: 2018-2022
Title: Innovations and Contributions of Michael J Boedigheimer
Introduction
Michael J Boedigheimer is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of medical treatments, particularly through his innovative patents. With a total of 3 patents, Boedigheimer's work focuses on advancing therapeutic methods that address critical health issues.
Latest Patents
One of his latest patents is titled "Methods of treatment using an interferon gamma inhibitor." This invention encompasses methods for treating diseases mediated by interferon gamma (IFN-γ) using inhibitors, such as anti-huIFN-γ antibodies. The patent outlines how levels of expression of specific biomarkers can be determined before and after the administration of the IFN-γ inhibitor. Additionally, it contemplates methods of treatment using pharmacodynamically effective doses of the anti-huIFN-γ antibody. Another significant patent is the "Assay for detecting TH1 and TH2 cell populations." This disclosure relates to a method for detecting T helper cell or CTL subpopulations in subjects affected by diseases with an immune component. The methods are valuable for assessing the efficacy of treatments by detecting shifts in T helper cells and CTLs.
Career Highlights
Michael J Boedigheimer is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions that enhance patient care and treatment outcomes. His expertise in immunology and therapeutic methods has positioned him as a key contributor in his field.
Collaborations
Throughout his career, Boedigheimer has collaborated with esteemed colleagues, including Andrew A Welcher and Kevin Gorski. These collaborations have fostered an environment of innovation and have led to the development of impactful medical solutions.
Conclusion
Michael J Boedigheimer's contributions to the field of medical treatments through his patents demonstrate his commitment to advancing healthcare. His innovative approaches and collaborations continue to influence the landscape of medical research and treatment methodologies.